Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
Femina ; 46(2): 110-114, 20180430.
Article in Portuguese | LILACS | ID: biblio-1050109

ABSTRACT

O feto é um ser alogênico de sucesso. O feto é um aloenxerto natural bem tolerado pelo organismo materno. Vários fatores contribuem para a tolerância materna ao feto: 1. O útero é um local do corpo imunologicamente privilegiado, protegido por uma barreira tecidual não imunogênica; 2. A promoção de uma resposta imunossupressora local pela mãe: a. A molécula HLA-G do MHC de classe Ib, expressa nas células da placenta, impede que as células NK matem a placenta; b. A catabolização do aminoácido essencial triptofano pela placenta impede que as células T da mãe tenham acesso ao feto; c. A secreção das citocinas TGF-ß, IL-4 e IL-10, pelo epitélio uterino e trofoblasto, tende a suprimir as respostas das células T da mãe; d. A secreção das citocinas TGF-ß e IL-10, pelas células T reguladoras, também inibe as respostas de células T maternas.(AU)


The fetus is a successful allogeneic being. The fetus is a natural allograft well tolerated by the maternal organism. Several factors contribute to maternal fetal tolerance: 1. The uterus is an immunologically privileged body site, protected by a non-immunogenic tissue barrier. 2. Promoting a local immunosuppressive response by the mother: a. The MHC class Ib HLA-G molecule, expressed on placental cells, prevents NK cells from killing the placenta; b. The catabolization of the essential amino acid tryptophan by the placenta prevents the mother's T cells from accessing the fetus; c. Secretion of TGF-ß, IL-4 and IL-10 cytokines by the uterine and trophoblast epithelium tends to suppress the T-cell responses of the mother; d. Secretion of TGF-ß and IL-10 cytokines by regulatory T cells also inhibits maternal T cell responses.(AU)


Subject(s)
Humans , Female , Pregnancy , T-Lymphocytes, Regulatory , Fetus/immunology , Major Histocompatibility Complex/immunology , Maternal-Fetal Exchange/immunology , Trophoblasts , Killer Cells, Natural , Allografts , Allogeneic Cells
2.
Clinics ; 70(6): 408-412, 06/2015. tab
Article in English | LILACS | ID: lil-749793

ABSTRACT

OBJECTIVES: Rheumatoid arthritis is a polygenically controlled systemic autoimmune disease. Rheumatoid vasculitis is an important extra-articular phenotype of rheumatoid arthritis that can result in deep cutaneous ulcers. The objective of this study was to establish a correlation between the frequency of major histocompatibility complex class I/II alleles and killer immunoglobulin-like receptor genotypes in patients with cutaneous rheumatoid vasculitis. METHODS: Using the Scott & Bacon 1984 criteria to diagnose rheumatoid vasculitis and after excluding any other causes such as diabetes, atherosclerosis, adverse drug reactions, infection, and smoking, patients who met the criteria were selected. All of the selected rheumatoid vasculitis patients presented deep cutaneous ulcers. Identification of the major histocompatibility complex class I/II and killer immunoglobulin-like receptor genotypes was performed by polymerase chain reaction assays of samples collected from the 23 rheumatoid vasculitis patients as well as from 80 controls (40 non-rheumatoid vasculitis RA control patients and 40 healthy volunteers). RESULTS: An association between the presence of the HLA-DRB1*1402 and HLA-DRB1*0101 alleles and cutaneous lesions in rheumatoid vasculitis patients and a correlation between the inhibitor KIR2DL3 and the HLA-C*0802 ligand in rheumatoid vasculitis patients were found. CONCLUSION: An association was found between the presence of the HLA-DRB1*1402 and HLA-DRB1*0101 alleles and the development of cutaneous lesions in rheumatoid vasculitis patients. Additionally, the HLA-C*0802 ligand protects these individuals from developing cutaneous lesions. .


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , HLA-C Antigens/genetics , Major Histocompatibility Complex/immunology , Receptors, KIR/genetics , /genetics , Rheumatoid Vasculitis/immunology , Skin Diseases, Vascular/immunology , Alleles , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Brazil , Flow Cytometry , Genotype , HLA-DRB1 Chains/genetics , Polymerase Chain Reaction , Rheumatoid Vasculitis/genetics , Skin Diseases, Vascular/genetics
3.
Einstein (Säo Paulo) ; 13(1): 153-156, Jan-Mar/2015.
Article in English | LILACS | ID: lil-745865

ABSTRACT

The setting for the occurrence of an immune response is that of the need to cope with a vast array of different antigens from both pathogenic and non-pathogenic sources. When the first barriers against infection and innate defense fail, adaptive immune response enters the stage for recognition of the antigens by means of extremely variable molecules, namely immunoglobulins and T-cell receptors. The latter recognize the antigen exposed on cell surfaces, in the form of peptides presented by the HLA molecule. The first part of this review details the central role played by these molecules, establishing the close connection existing between their structure and their antigen presenting function.


O cenário no qual ocorre a resposta imune é o da necessidade de fazer frente a uma vasta gama de antígenos diferentes, de fontes patogênicas e não patogênicas. Quando as primeiras barreiras contra infecção e a defesa inata falham, a resposta imune adaptativa entra em campo, para efetuar o reconhecimento dos antígenos, utilizando, para esse fim, moléculas extremamente variáveis, que são as imunoglobulinas e os receptores de células-T. Estes últimos reconhecem o antígeno, exposto na superfície das células como peptídeo apresentado pelas moléculas HLA. A primeira parte desta revisão detalha o papel central dessas moléculas, estabelecendo a conexão que existe entre a estrutura e a função de apresentação de antígenos.


Subject(s)
Humans , Antigen Presentation/immunology , HLA Antigens/immunology , Major Histocompatibility Complex/immunology , Alleles , Antigen Presentation/genetics , HLA Antigens/genetics , Major Histocompatibility Complex/genetics
4.
Einstein (Säo Paulo) ; 13(1): 157-162, Jan-Mar/2015.
Article in English | LILACS | ID: lil-745874

ABSTRACT

The second part of this review deals with the molecules and processes involved in the processing and presentation of the antigenic fragments to the T-cell receptor. Though the nature of the antigens presented varies, the most significant class of antigens is proteins, processed within the cell to be then recognized in the form of peptides, a mechanism that confers an extraordinary degree of precision to this mode of immune response. The efficiency and accuracy of this system is also the result of the myriad of mechanisms involved in the processing of proteins and production of peptides, in addition to the capture and recycling of alternative sources aiming to generate further diversity in the presentation to T-cells.


A segunda parte desta revisão trata das moléculas e processos envolvidos no processamento e apresentação dos fragmentos antigênicos ao receptor de célula-T. Apesar de variar a natureza do antígeno apresentado, a classe mais significativa é a das proteínas, as quais são processadas dentro da célula para enfim serem reconhecidas na forma de peptídeos, o que confere um grau extraordinário de precisão a essa forma de resposta imune. A eficiência e a precisão desse sistema se devem também à miríade de mecanismos envolvidos no processamento de proteínas e produção de peptídeos, além da captura e reciclagem de fontes alternativas de antígenos com o objetivo de gerar ainda maior diversidade na apresentação à célula-T.


Subject(s)
Humans , Antigen Presentation/immunology , Cell-Penetrating Peptides/metabolism , HLA Antigens/metabolism , Major Histocompatibility Complex/immunology , Cell-Penetrating Peptides/immunology , HLA Antigens/immunology
5.
Mem. Inst. Oswaldo Cruz ; 108(2): 212-219, abr. 2013. graf
Article in English | LILACS | ID: lil-670398

ABSTRACT

Astrocytes play a vital role in neuronal protection, homeostasis, vascular interchange and the local immune response. Some viruses and parasites can cross the blood-brain barrier and infect glia. Trypanosoma cruzi, the aetiological agent of Chagas disease, can seriously compromise the central nervous system, mainly in immune-suppressed individuals, but also during the acute phase of the infection. In this report, the infective capacity of T. cruzi in a human astrocyte tumour-derived cell line was studied. Astrocytes exposed to trypomastigotes (1:10 ratio) produced intracellular amastigotes and new trypomastigotes emerged by day 4 post-infection (p.i.). At day 6 p.i., 93% of the cells were infected. Using flow cytometry, changes were observed in both the expression of major histocompatibility complex class I and II molecules and the chemokine secretion pattern of astrocytes exposed to the parasite. Blocking the low-density lipoprotein receptor on astrocytes did not reduce parasite intracellular infection. Thus, T. cruzi can infect astrocytes and modulate the immune response during central nervous system infection.


Subject(s)
Humans , Astrocytes/parasitology , Astrocytoma/parasitology , Immunity, Cellular/immunology , Trypanosoma cruzi/physiology , Astrocytoma/immunology , Blood-Brain Barrier/immunology , Cell Line, Tumor , Major Histocompatibility Complex/immunology , Time Factors
6.
Yonsei Medical Journal ; : 241-247, 2012.
Article in English | WPRIM | ID: wpr-154822

ABSTRACT

Autophagy is a specialized cellular pathway involved in maintaining homeostasis by degrading long-lived cellular proteins and organelles. Recent studies have demonstrated that autophagy is utilized by immune systems to protect host cells from invading pathogens and regulate uncontrolled immune responses. During pathogen recognition, induction of autophagy by pattern recognition receptors leads to the promotion or inhibition of consequent signaling pathways. Furthermore, autophagy plays a role in the delivery of pathogen signatures in order to promote the recognition thereof by pattern recognition receptors. In addition to innate recognition, autophagy has been shown to facilitate MHC class II presentation of intracellular antigens to activate CD4 T cells. In this review, we describe the roles of autophagy in innate recognition of pathogens and adaptive immunity, such as antigen presentation, as well as the clinical relevance of autophagy in the treatment of human diseases.


Subject(s)
Animals , Humans , Adaptive Immunity/immunology , Antigen Presentation/immunology , Autophagy/immunology , Major Histocompatibility Complex/immunology
7.
Int. j. morphol ; 28(3): 713-718, Sept. 2010. ilus
Article in Spanish | LILACS | ID: lil-577175

ABSTRACT

El inicio y establecimiento de la gestación en los mamíferos dependen de la adaptación del sistema inmunológico de la madre para tolerar un feto semi-alogénico. La gestación en sí misma constituye un acontecimiento de equilibrio inmunológico, ya que mientras el sistema inmune mantiene la competencia para la defensa contra antígenos foráneos, mecanismos de tolerancia local y periférica previenen una respuesta inapropiada contra alo-antígenos fetales de origen paterno lo que pudiera provocar el rechazo del feto. La interacción materno-fetal es extremadamente compleja y es difícil determinar todos los componentes del sistema inmune involucrados. Hasta ahora se ha demostrado la participación activa de las células T y sus productos, las citoquinas y también se ha involucrado a las moléculas del complejo mayor de histocompatibilidad, los antígenos paternos y algunos inmunomoduladores como progesterona, indoleamina 2,3-dioxigeneasa y glicodelina, entre otros. Todos estos elementos parecen confluir para producir un gran cambio sistémico en el sistema inmune materno, promoviendo por una parte la tolerancia materno-fetal, crucial para finalmente permitir una gestación exitosa y, por otro lado, manteniendo una activa vigilancia inmune contra las infecciones que pondrían en riesgo la gestación y sobrevivencia de diversas especies. Se revisó la literatura más reciente acerca de los diferentes componentes del sistema inmune que han demostrado ser clave en el inicio y mantención de la gestación en mamíferos.


The initiation and establishment of pregnancy in mammals depends on the adaptation from maternal immune system to tolerate a semi-allogeneic fetus. Pregnancy itself constitutes an event of immune balance because, while the immune system maintains the capacity for defense against foreign antigens, mechanisms of local and peripheral tolerance may prevent an inappropriate response against fetal alloantigens of paternal origin which could lead to rejection of the fetus. The maternal-fetal immune interaction is extremely complex and it has therefore been difficult to identify all the immune components involved. So far, it is known that the active participation of T cells and their products, cytokines, and has also involved molecules from the major histocompatibility complex, other paternal antigens and some immunomodulators molecules such as progesterone, glycodelin and indoleamine 2,3-dioxigenase among others. All these elements seem to converge to produce a major systemic change in the maternal immune system, promoting on one hand the maternal-fetal tolerance, crucial to allow a successful pregnancy and on the other hand, maintaining an active immune surveillance against infections that might endanger pregnancy and survival of diverses species. A review of recent literature about the different components of the immune system that have proven key in the beginning and maintenance of pregnancy in mammals.


Subject(s)
Humans , Animals , Female , Pregnancy , Pregnancy/immunology , Fetus/immunology , Maternal-Fetal Exchange/immunology , Killer Cells, Natural/immunology , Major Histocompatibility Complex/immunology , Pregnancy/physiology , Histocompatibility, Maternal-Fetal/immunology , Immune Tolerance , Immunologic Factors , T-Lymphocytes, Regulatory/immunology , Pregnancy, Animal/immunology
9.
An. acad. bras. ciênc ; 80(1): 85-99, Mar. 2008. graf, tab
Article in English | LILACS | ID: lil-477417

ABSTRACT

Toxoplasma gondii strains displaying the Type I/III genotype are associated with acquired ocular toxoplasmosis in humans. Here, we used a mice model to characterize some immunological mechanisms involved in host resistance to infection with such strains. We have chosen the Type I/III strains D8, G2 and P-Br, which cause a chronic infection in mice that resembles human toxoplamosis. Mice deficient of molecules MyD88, IFN-gamma, and IL-12 were susceptible to all three parasite strains. This finding indicates the importance of innate mechanisms in controlling infection. On the other hand, MHC haplotype did not influenced resistance/susceptibility; since mice lineages displaying a same genetic background but different MHC haplotypes (H2b or H2d) developed similar mortality and cyst numbers after infection with those strains. In contrast, the C57BL/6 genetic background, and not MHC haplotype, was critical for development of intestinal inflammation caused by any of the studied strains. Finally, regarding effector mechanisms, weobserved that B and CD8+ T lymphocytes controlled survival,whereas the inducible nitric oxide synthase influenced cyst numbers in brains of mice infected with Type I/III strains. These findings are relevant to further understanding of the immunologic mechanisms involved in host protection and pathogenesis during infection with T. gondii.


Cepas de Toxoplasma gondii que apresentam o genótipo I/III são associadas a toxoplasmose ocular adquirida em humanos. No presente trabalho, nós utilizamos um modelo da doença em camundongos para caracterizar mecanismos imunológicos envolvidos na resistência do hospedeiro à infecção por aquelas cepas. Escolhemos as cepas D8, G2 e P-Br, que causam infecção crônica em camundongos, semelhante à toxoplasmose humana. Camundongos deficientes em MyD88, IFN-G e IL-12 foram susceptíveis a infecções com todas as três linhagens do parasita. Esses dados indicam a importância de mecanismos inatos no controle da infecção. Por outro lado, o haplótipo do MHC não influenciou na resistência/susceptibilidade, na medida em que linhagens de camundongos com um mesmo "background'' genético, mas diferentes haplótipos de MHC (H2b e H2d) apresentam o índice de mortalidade e número de cistos semelhantes após a infecção com aquelas cepas do parasita. Em contraste, o "background'' genético de C57BL/6, mas não o haplótipo de MHC, foi crítico para o desenvolvimento de inflamação intestinal causada pelas cepas estudadas. Finalmente, com relação aos mecanismos efetores, observamos que linfócitos B e T CD8+ controlam a sobrevivência após infecção. Por outro lado, a ativação da enzima óxido nítrico sintase induzida foi um fator importante para controle do número de cistos cerebrais em camundongos infectados com cepas do Tipo I/III. Esses achados são relevantes para o melhor entendimento dos mecanismos imunológicos envolvidos na proteção e patogênese durante infecção com T. gondii.


Subject(s)
Animals , Mice , Haplotypes/genetics , Major Histocompatibility Complex/genetics , Mice, Inbred Strains/immunology , Toxoplasma/genetics , Toxoplasmosis, Animal/immunology , Toxoplasmosis, Cerebral/immunology , Disease Models, Animal , Genotype , Interferon-gamma/deficiency , Interferon-gamma/immunology , /deficiency , /immunology , Major Histocompatibility Complex/immunology , Mice, Inbred Strains/genetics , /deficiency , /immunology , Time Factors , Toll-Like Receptors/immunology , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/parasitology , Toxoplasmosis, Animal/pathology , Toxoplasmosis, Cerebral/parasitology , Toxoplasmosis, Cerebral/pathology , Virulence/genetics
10.
Acta gastroenterol. latinoam ; 36(2): 86-93, jun. 2006. tab
Article in Portuguese | LILACS | ID: lil-440724

ABSTRACT

Fatores genéticos, imunológicos e ambientais estão envolvidos na patogênese de doenças gastrintestinais. Situado no braço curto do cromossomo 6, o sistema HLA se destaca pelo seu polimorfismo e capacidade de conferir susceptibilidade ou resistência a vários distúrbios imunomediados. De acordo com a patologia e, algumas vezes, com o grupo étnico-racial estudado, existem variações na associação HLA x doença. Acredita-se que moléculas de histocompatibilidade possam influenciar na idade de surgimento, resposta ao tratamento e no curso clínico de algumas enfermidades. O surgimento de novos métodos para tipificação dos alelos HLA assim como as mudanças em sua nomenclatura têm permitido um melhor entendimento desse sistema. Infelizmente, esse conhecimento não tem sido adequadamente veiculado na literatura clínica. Esta revisão tem porobjetivo abordar a estrutura e função do sistema HLA, seus métodos de detecção, nomenclatura e associação com doença celíaca, doença de Crohn, hepatite autoimune, pancreatite auto-imune e úlceras orais recorrentes.


Los factores genéticos, inmunológicos y ambientales están envueltos en la patogénesis de las enfermedades gastrointestinales. Situado en el brazo corto del cromosoma 6, el sistema HLA se destaca por su polimorfismo y capacidad de conferir susceptibilidad o resistencia a varios disturbios inmunomediados. De acuerdo con la patología y algunas veces con el grupo étnico-racial estudiado, existen variaciones en la asociación HLA yenfermedades. El surgimiento de nuevos métodos para tipificación de los alelos así como los cambios en su Nomenclatura ha permitido un mejor entendimiento de este sistema. Infelizmente, ese conocimiento no ha sido adecuadamente vehiculazado en la literatura clínica. Esta revisión tiene por objeto abordar la estructura y función del sistema HLA, sus métodos de detección, nomenclatura y asociación con la enfermedad celíaca, enfermedad de Crohn, hepatitis auto-inmune, pancreatitis auto-inmune y úlceras orales-recurrentes.


Genetic, immunological and environmental factors are involved in the pathogenesis of the gastrointestinal diseases. Situated on the short arm of the chromosome 6, the HLA system is very polymorphic and has the capacity to confer susceptibility or resistance to different diseases. The relationship HLA vs. disease differs with the disease and, sometimes, with the ethnic-racial group studied. Histocompatibility molecules could determine the age of onset, the treatment response and the clinical course for some diseases. The recent discovery of new methods to typify HLA alleles and the changes in its nomenclature has contributed to a better understanding of this system. Nevertheless, has not thoroughly widespread. The aim of this review is to discuss the HLA structure and function, methods of detection, nomenclature and its association with celiac disease, Crohn’s disease, autoimmune hepatitis, autoimmune pancreatitis and oral recurrent ulcers.


Subject(s)
Humans , Gastrointestinal Diseases/genetics , Gastrointestinal Diseases/immunology , HLA Antigens/genetics , Major Histocompatibility Complex/genetics , Genetic Predisposition to Disease , HLA Antigens/immunology , Major Histocompatibility Complex/immunology
11.
Braz. j. infect. dis ; 10(2): 122-131, Apr. 2006.
Article in English | LILACS | ID: lil-431985

ABSTRACT

Many studies have tried to identify genetic markers for infectious diseases, some of them have focused on human leukocyte antigens (HLA). The products of HLA genes interact with surface-specific receptors of T lymphocytes, resulting in activation of the host's immune response. Association of bacterial, viral, parasitic and fungal infections with the host's HLA has been widely investigated. The type and strength of this association differs among distinct populations, as well as among racial and/or ethnic groups. The new molecular methods for the identification of the HLA alleles, and the resulting new nomenclature, have contributed to a better understanding of this system. Unfortunately, this information has not been adequately transmitted to clinicians, which hampers the understanding of the association between the HLA system and diseases. We revised relevant studies on the association of HLA genes with infectious diseases, demonstrating their importance in the pathogenic mechanisms, through increased susceptibility or protection against infections and their complications.


Subject(s)
Humans , Communicable Diseases/genetics , Communicable Diseases/immunology , Major Histocompatibility Complex/genetics , Major Histocompatibility Complex/immunology , Alleles , Bacterial Infections/genetics , Bacterial Infections/immunology , HLA Antigens/genetics , HLA Antigens/immunology , Immunogenetics , Parasitic Diseases/genetics , Parasitic Diseases/immunology , Virus Diseases/genetics , Virus Diseases/immunology
12.
Arq. bras. med. vet. zootec ; 57(3): 380-389, jun. 2005.
Article in Portuguese | LILACS | ID: lil-415158

ABSTRACT

A associação entre os alelos do loco BoLA-DRB3.2, identificados pela técnica de PCR-RFLP, e a produção de leite na raça Gir foi estudada por meio da análise de dados moleculares e fenotípicos de 424 vacas Gir, utilizando um modelo misto, sob modelo animal. Os dados moleculares consistiam dos genótipos dos animais para os alelos do loco BoLA-DRB3.2 e os dados fenotípicos eram referentes à produção de leite em até 305 dias de lactação. O loco é altamente polimórfico nesta raça, sendo identificados sete alelos (BoLA-DRB3.2*4, *8, *11, *19, *28, *41 e *48) que não haviam sido encontrados em animais zebuínos. Dois alelos (*16 e *29) estavam significativamente associados com maiores produções de leite, sugerindo que o próprio loco BoLA-DRB3.2 ou um QTL a ele ligado influencia a produção de leite de vacas Gir.


Subject(s)
Alleles , Cattle , Major Histocompatibility Complex/genetics , Major Histocompatibility Complex/immunology , Food Production , Lactation/genetics , Polymerase Chain Reaction
14.
Pediatria (Säo Paulo) ; 27(4): 274-286, 2005. tab
Article in Portuguese | LILACS | ID: lil-424791

ABSTRACT

Objetivo: a compreensão da base molecular das doenças é cada vez mais importante para seu diagnóstico, prevenção e tratamento. São objetivos dese trabalho: revisar a estrutura e função dos antígenos de histocompatibilidade humanos(HLA: Human Leukocyte Antigen), mostrar a sua importância na prática médica e descrever seus mecanismos de asociação com transplantes, transfusão e as principais doenças de interese para o pediatra / Objectives: The comprehension of the molecular basis of diseases is increasingly important for its diagnosis, prevention and treatment. This article aims to review the structure and function of human histocompatibility antigens (HLA: Human Leukocyte Antigens), to demonstrate its importance in medical practice and decribe its asociated mechanisms with transplantation, tansfusion and diseases commonly seen by the pediatrician...


Subject(s)
Humans , Major Histocompatibility Complex/immunology , Blood Transfusion , Transplantation
15.
Arq. neuropsiquiatr ; 62(4): 923-934, dez. 2004. ilus, tab, graf
Article in English | LILACS | ID: lil-390661

ABSTRACT

OBJETIVO: Caracterizar as células do infiltrado inflamatório, o padrão de expressão das moléculas de adesão (ICAM-1 e VCAM-1), complexo de ataque à membrana (C5b-9) e antígenos de histocompatibilidade maior (MHC) em biópsias musculares de patientes com doença mista do tecido conectivo (DMTC). MÉTODO: Foram estudados14 pacientes com DMTC e comparadas com 8 pacientes com polimiosite (PM), 5 com dermatomiosite (DM) e 4 com distrofias. As células inflamatórias foram caracterizadas como CD4+, CD8+, células T de memória (CD45RO+) e virgens, células "natural killer" e macrófagos. As expressões de MHC-I e ûII, ICAM-1, VCAM-1 e C5b-9 foram caracterizadas em fibras musculares e vasos. RESULTADOS:A análise morfológica demonstrou um padrão tipo PM. O estudo imuno-histoquímico revelou diminuição do número de capilares, predomínio de células CD4+ e B nas regiões perivasculares e predomínio de CD8+ e CD45RO+ nas regiões endomisiais. A expressão de MHC-I nos vasos e nas fibras degeneradas, MHC-II nos vasos e fibras perifasciculares e expressão de ICAM-1 / VCAM-1 no endotélio indicaram uma associação de processos vascular e imune-celular mediando a lesão muscular. CONCLUSAO: Os achados revelaram duplo mecanismo na DMTC, imune-celular como na PM e vascular como na DM.


Subject(s)
Adult , Middle Aged , Humans , Male , Female , Cell Adhesion Molecules/immunology , Dermatomyositis/immunology , Dermatomyositis/pathology , Major Histocompatibility Complex/immunology , Mixed Connective Tissue Disease/immunology , Vascular Cell Adhesion Molecule-1/immunology , Age Distribution , Antigens, CD/immunology , Autoantibodies/blood , Biopsy , Gene Expression Regulation/immunology , Immunohistochemistry , Mixed Connective Tissue Disease/pathology , Sex Distribution
16.
Article in English | IMSEAR | ID: sea-17723

ABSTRACT

The immune system needs to recognise target protein antigens from pathogens residing in both extracellular and intracellular locations. Intricate proteolytic processing events that follow antigen/ pathogen encounter provide the immune system with a complex display of a heterogeneous peptide mix, instrumental in the initiation of T cell immune responses, and allow the separation of extracellular and intracellular pathogen identification. However, recent evidence shows that this conventional dimorphism in the proteolytic processing of endogenous versus internalised antigen is less restrictive than originally recognized. The events that constitute the conventional major histocompatibility complex (MHC)-restricted processing pathways are accompanied by interesting deviations that provide novel adjuncts for the processing machinery to gain access to antigen in varied intracellular locations. This review discusses these aspects of classical and non-classical processing pathways for MHC-restricted protein presentation, which play significant roles in both optimising and diversifying the peptide repertoire available for immune recognition.


Subject(s)
Antigen Presentation , Antigens/immunology , Endopeptidases/metabolism , Histocompatibility Antigens Class I , Histocompatibility Antigens Class II , Humans , Major Histocompatibility Complex/immunology , Molecular Chaperones/metabolism , T-Lymphocytes/immunology
17.
Article in English | IMSEAR | ID: sea-63533

ABSTRACT

OBJECTIVES: Outcome after acute hepatitis B virus (HBV) infection may be determined by the host immune system. We studied the distribution of major histocompatibility (MHC) antigens in patients who developed natural immunity against HBV and those with chronic hepatitis B. METHODS: Thirty patients positive for IgG anti-HBs and anti-HBc ('naturally immune'), 30 patients with HBsAg-positive chronic hepatitis and 30 subjects with no serological markers of HBV infection (controls) were studied. MHC class-I antigens were detected by the standard Terasaki microlymphocytotoxicity test and the MHC class-II antigens by a polymerase chain reaction using sequence-specific primers. RESULTS: In the naturally immune group, A11, B73, CW3, DRB1*16 and DQB1*05 antigens were significantly more frequent than in the control group, and B73, DRB1*04 and DRB1*13 antigens were more frequent than in the chronic hepatitis group. In the chronic hepatitis group, CW6, DRB5 and DQB1*05 antigens were significantly more frequent than in the control group, and B8, CW7, DRB1*03 and DQB1*02 antigens were more frequent than in the naturally immune group. CONCLUSIONS: Differences in alleleic frequencies of HLA among persons with natural immunity against HBV and those with chronic hepatitis B may suggest a genetic basis for persistence of HBV infection and occurrence of chronic liver disease.


Subject(s)
Adult , Case-Control Studies , Female , HLA Antigens/immunology , Hepatitis B, Chronic/immunology , Humans , Major Histocompatibility Complex/immunology , Male , Prognosis , Risk Factors
18.
Rev. chil. pediatr ; 71(4): 296-306, jul.-ago. 2000. tab
Article in Spanish | LILACS | ID: lil-274582

ABSTRACT

Las células tumorales ven alterada la regulación de su ciclo celular y comienzan a proliferar en forma descontrolada debido a mutaciones en su material genético. Además de las alteraciones en la proliferación, se producen modificaciones genéticas que dan origen a cambios en la expresión de proteínas en la célula maligna, lo que se manifiesta en la sobreexpresión de algunos genes o en su activación en tejidos normales, en los que comúnmente no son expresados. Estos genes originan proteínas que pueden ser reconocidas como aberrantes por el sistema inmune, generando una respuesta antitumoral. Recientemente, estudios realizados en animales de experimentación y en pacientes han demostrado que la principal actividad antitumoral está dada por la respuesta inmune celular. En esta situación, son los linfocitos T los que juegan un papel preponderante, reconociendo, a través de su receptor, antígenos que han sido procesados y presentados en asociación con las moléculas del complejo principal de histocompatibilidad (MHC). La gran mayoría de los antígenos asociados a tumor (AAT) y reconocidos por linfocitos T CD8+ citotóxicos (CTL) son péptidos derivados de proteínas que se expresan en las céluolas tumorales y además se encuentran en el tejido normal que les dio origen. Así, en melanoma humano por ejemplo, existen antígenos inmunodominantes derivados de proteínas involucradas en la síntesis de melanina y expresados tanto en el tumor como en los melanocitos normales. Existen otros antígenos restringidos por MHC que son comunes a varios tipos de tumores. Estos derivan de proteínas embrionarias y normalmente no se expresan en tejidos somáticos. La identificación de varios AAT ha permitido desarrollo de modernas vacunas antitumorales, las que se encuentran en etapa de experimentación. Estas vacunas, basadas en los antígenos descritos, pueden ser de tipo peptídico o de ADN y vendrían a reemplazar las terapias inmúnológicas menos específicas, como el tratamiento con citoquinas o las terapias adoptivas. Investigaciones clínicas y preclínicas llevadas a cabo durante los últimos dos años indican que la forma de inmunizar resulta esencial para inducir una respuesta inmune efectiva y evitar la anergia o tolerancia. Aquí juegan un papel determinante las células dendríticas en su función de células presentadoras de antígenos profesionales y algunas citoquinas proinflamatorias


Subject(s)
Humans , Immune System/immunology , Neoplasms/immunology , Cytokines/immunology , Cytokines/therapeutic use , Major Histocompatibility Complex/immunology , T-Lymphocytes/immunology , Immunologic Surveillance/immunology
19.
Braz. j. med. biol. res ; 32(2): 199-205, feb. 1999.
Article in English | LILACS | ID: lil-228261

ABSTRACT

The target of any immunization is to activate and expand lymphocyte clones with the desired recognition specificity and the necessary effector functions. In gene, recombinant and peptide vaccines, the immunogen is a single protein or a small assembly of epitopes from antigenic proteins. Since most immune responses against protein and peptide antigens are T-cell dependent, the molecular target of such vaccines is to generate at least 50-100 complexes between MHC molecule and the antigenic peptide per antigen-presenting cell, sensitizing a T cell population of appropriate clonal size and effector characteristics. Thus, the immunobiology of antigen recognition by T cells must be taken into account when designing new generation peptide- or gene-based vaccines. Since T cell recognition is MHC-restricted, and given the wide polymorphism of the different MHC molecules, distinct epitopes may be recognized by different individuals in the population. Therefore, the issue of whether immunization will be effective in inducing a protective immune response, covering the entire target population, becomes an important question. Many pathogens have evolved molecular mechanisms to escape recognition by the immune system by variation of antigenic protein sequences. In this short review, we will discuss the several concepts related to selection of amino acid sequences to be included in DNA and peptide vaccines


Subject(s)
Humans , Antigen Presentation , Major Histocompatibility Complex/immunology , Peptides , Vaccines, Synthetic , T-Lymphocytes
20.
Rev. mex. reumatol ; 13(4): 168-71, jul.-ago. 1998. tab
Article in Spanish | LILACS | ID: lil-241067

ABSTRACT

Objetivo: La artritis reumatoide (AR) es una enfermedad multifactorial y sistémica del tejido conjuntivo. Caracterizada por afección simétrica de las articulares pequeñas de las manos y pies, en etapas tardías puede también involucrar articulaciones mayores. La afección es dada básicamente por un proceso inflamatorio. La AR es más frecuente en mujeres (2 a 7 veces). Los antígenos leucocitarios humanos (HLA) están involucrados en la patología de la enfermedad. El HLA es parte del complejo principal de histocompatibilidad (CPH), localizado en el brazo corto del cromosoma 6. El CPH se ha subdividido en 3 grupos. Las moléculas clase II se expresan en los linfocitos B, linfocitos T activados, macrófagos, células de Langerhans, dendríticas y endoteliales. El objetivo principal del presente estudio fue buscar una asociación entre éstos antígenos y la AR en paciente adultos del sexo masculino. Métodos. Se incluyeron 35 pacientes de sexo masculino cuya edad media fue de 45.2 años (rango de 25 a 67), con diagnóstico de AR (según los cirterios del ACR) que asisten a la consulta del Servicio de Reumatología del Hospital Regional 20 de noviembre del ISSSTE, estudiados en forma prospectiva de junio de 1989 a julio de 1990. Se estudió la clase funcional, la clase anatómica y se determinó la presencia del factor reumatoide. Resultados: Los resultados fueron: clase funcional I en 17.1 por ciento, II en 60 por ciento, III en 20 por ciento y IV en 28 por ciento. Todos los pacientes fueron seropositivos para factor reumatoide tipo IgM por nefelometría. Los antígenos de histocompatibilidad Clase II fueron: DR5 en 25 por ciento, DR4 en 15 por ciento y DR3 y DR7 en 13.3 por ciento


Subject(s)
Humans , Male , Adult , Middle Aged , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/immunology , Rheumatoid Factor , Haplotypes/immunology , Histocompatibility Testing , Major Histocompatibility Complex/genetics , Major Histocompatibility Complex/immunology , HLA Antigens/blood , HLA Antigens
SELECTION OF CITATIONS
SEARCH DETAIL